ASMB · Assembly Biosciences Inc
United States · RS rating 21 · As of 2026-11-03
| Price | 19.92 USD |
|---|---|
| 1-day change | +2.1% |
| RS rating (overall / 1M / 3M / 12M) | 21 / 31 / 26 / 28 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 31 / 7 / 50 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +63.0% |
| Sales growth Q/Q | +293.6% |
| Distance from 52-week high | +48.3% |
| Market cap (USD) | $450.2M |